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Abstract • Background: The po- 
tent vasoconstrictor peptide endo- 
thelin-I has been shown to partici- 
pate in the control of peripheral 
vascular tone and in the regulation 
of ocular perfusion. In glaucoma 
patients vasospasms and arterial hy- 
potension have been identified as 
risk factors for the progression of 
glaucomatous damage, and the reg- 
ulation of endothelin- 1 release is 
disturbed in some of these patients. 
The aim of this study was to assess 
the relationship between resting 
blood pressure and cutaneous vas- 
cular responsiveness to endothelin- 
1 and phenylephrine in patients 
with glaucoma nd in matched 
controls. • Methods: In 9 patients 
with primary open-angle glaucoma 
(POAG), 7 patients with normal 
tension glaucoma (NTG), and 16 
age- and sex-matched controls, 
endothelin- 1 and phenylephrine 
responses were assessed in the hu- 
man forearm microcirculation using 
laser Doppler f lowmetry during 
intra-arterial drug administration. 
Blood pressure was measured intra- 
arterially. • Results: In contrast 
to a~-adrenergic effects, endothe- 
lin-1 responses were inversely cor- 
related to both systolic (r e = 0.27, 
P = 0.05) and diastolic (re =- 0.54, 
P = 0.001) blood pressure in glau- 
coma patients, whereas there was 
no such correlation in controls. Pa- 
tients with lower blood pressure val- 
ues were more sensitive to the vaso- 
constrictor effects of endothelin- 1. 
Cutaneous responsiveness to endo- 
thelin-1 and phenylephrine was 
similar in glaucoma patients and in 
controls. • Conclusion: These re- 
sults reveal that glaucoma patients 
appear to have peripheral microvas- 
cular abnormalities which are ex- 
hibited as altered responsiveness to 
endothelin-1. Thus, this study sup- 
ports the hypothesis that endothe- 
l in-l-related microvascular dys- 
function may be involved in the 
pathogenesis of glaucomatous dam- 
age. 
Introduction 
Glaucomatous damage of the eye is characterized by 
progressive nerve fiber loss combined with excavation of 
the optic nerve head and visual field damage. Besides 
increased intraocular pressure and systemic arterial hy- 
potension [15, 17], vasospastic diathesis has been identi- 
fied as a further risk factor for the occurrence and pro- 
gression of such a damage [8, 12]. Hence, in the patho- 
genesis of glaucoma dditional factors affecting the vas- 
culature in general must be involved [9]. Also circulatory 
defects of the optic disk have been described in patients 
with glaucoma [32], although it is still unclear whether 
these disturbances are cause or consequence of the visual 
field defects. One of the major endogenous factors regu- 
lating eye perfusion is endothelin- 1 [23], the plasma con- 
centration of which is increased in those glaucoma pa- 
tients who have normal intraocular pressure [18, 24]. 
In the present study we evaluated the sensitivity of the 
microcirculation to two prototype vasoconstrictors, 
635 
phenylephrine and endothelin-1, and assessed the rela- 
tionship between individual vascular esponsiveness and 
resting intra-ar terial blood pressure in glaucoma patients 
and in healthy controls. 
tive values. Group comparisons were done with the Mann-Whitney 
U-test, and correlations were done by linear regression analysis. 
Pairs of averaged ose-response curves were evaluated with analy- 
sis of variance (ANOVA) for repeated measurements. A P value of 
<0.05 was considered significant. 
Patients and methods 
After giving written informed consent, 16 age- and sex-matched 
controls (mean age 63 years, range 28-73; 7 women, 9 men) and 
16 otherwise healthy glaucoma patients (mean age: 61 years, range 
26-74; 6 women, 10 men) with open anterior chamber angle and 
characteristic glaucomatous visual field defects and/or optic nerve 
damage were included. The study was approved by the ethics com- 
mittee of the Department of Medicine, University Hospital Basel, 
Switzerland. Nine patients had primary open-angle glaucoma 
(POAG; intraocular pressure consistently >21 mmHg; mean 
age _+ SEM 62 + 4 years, range 34-7l  years), and seven had 
normal-tension glaucoma (NTG; untreated intraocular pressure 
--<21 mmHg; age 59 _+ 6 years, range 26-75 years). Patients and 
controls underwent complete blood analysis for exclusion of severe 
hematologic, renal, or hepatic dysfunction. In addition, serum 
lipids, including HDL and LDL fractions, were detelwnined and 
were found to be similar in both groups. Patients with known vas- 
cular disease, concurrent drug use, or smoking were excluded. In 
glaucoma patients, systemically administered drugs were discon- 
tinued at least 14 days, topically administered drugs at least 7 days 
before the study. Controls were not taking any medication, were 
not suffering from any concurrent disease, and their medical histo- 
ry was not remarkable for cardiovascular, liver or kidney disorders. 
All studies were done in the morning with the patient semire- 
cumbent in bed. Under local anesthesia an 18-gauge catheter was 
inserted into the left brachial artery for blood pressure recording 
(Statham P23 Pb pressure transducer) and regional drug adminis- 
tration. Drugs were infused at a constant flow rate (1 ml/min), and 
doses were adjusted according to forearm volume. After reaching 
a stable baseline during infusion of solvent (Physiogel, 4% gelatin 
solution, Swiss Red Cross, Bern, Switzerland), increasing doses 
of phenylephrine (Neo-Synephrine, Winthrop, Mtinchenstein, 
Switzerland; 0.3-t0 btg/min/100 ml tissue) and endothelin-1 
(Clinalfa AG, L~ufelfingen, Switzerland; 0.005-25 ng/min/  
100 ml tissue) were administered into the brachial artery for 5 min 
to construct cumulative dose-response curves. The two drug ad- 
ministrations were separated by a washout phase of sufficient 
length to allow forearm blood flow to return to baseline values 
(approximately 60 rain). The short-acting phenylephrine was al- 
ways administered first, since the effect of endothelin-1 may last 
for several hours and may, therefore, confound the effects of subse- 
quently administered vasoactive compounds [37]. Changes in cu- 
taneous blood cell velocity were measured with a laser Doppler 
flowmeter [2-roW helium-neon laser, light wavelength 632.8 nm, 
wide band mode (20-12 000 Hz); Periflux PF3, Perimed, Sweden] 
[3]. The laser probe (PF 308, Periflux) was fixed on the lateral 
ventral forearm with a thermostat probe holder (PF 206, Periflux) 
heated to 34°C. The baseline immediately before drug application 
was set to 100%, and flow was expressed as percentage change 
from this baseline. The last 24 s of each drug infusion was used for 
evaluation. 
Individual phenylephrine dose-response curves, expressed as 
percentage change from baseline, were fitted to a sigmoid model 
by use of a nonlinear least-squares regression program (Allfit) 
providing estimates of the maximum effect (Emax) and the dose- 
rate producing 50% of Emax (EDso) [6]. Endothelin-1 dose-re- 
sponse curves were biphasic and, therefore, not evaluated with a 
sigmoid model: For these semilogarithmic curves, area under the 
curve (AUC) values were calculated using the trapezoidal rule, 
with vasodilation expressed as positive and constriction as nega- 
Results 
Intra-arterial systolic and diastolic blood pressure values 
measured at baseline before administration of drugs 
were 117 ~_~ 4/56 _+ 1 mmHg in glaucoma patients and 
122 + 3/57 _+ 2 mmHg in the control group (P >0.3 for 
diastolic and systolic values). The effect of intra-arterial 
endothelin-1 was biphasic in all controls and in all but 
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Fig. 2 Linear correlation between cutaneous vasoconstriction af- 
ter infusion of endothelin-1 (expressed as AUC values) and intra- 
arterial diastolic blood pressure (mmHg) at baseline in 16 patients 
with glaucoma (O) ; t 2 = 0.52, P = 0.002; AUC = -634 + 11.3 
(0) (diastolic blood pressure)] and 16 age- and sex-matched con- 
trols (O; j2 _ 0.068, P = 0.33) 
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Fig. 3 Mean changes in cutaneous blood flow recorded in 16 pa- 
tients with glaucoma (Q) and 16 age- and sex-matched controls 
(©) during intra-arterial administration of increasing dosages of 
phenylephrine. Emax and EDso values of the two fitted dose- 
response curves were not significantly different 
curves of the two groups were similar (P = 0.8). At lower 
dose-rate the peptide induced vasodilation, whereas at 
higher dose-rate pronounced vasoconstriction ccurred. 
While there was no significant relationship between 
blood pressure values and endothelin-1 responsiveness in 
control subjects, vasoconstriction was inversely correlat- 
ed with intra-arterial blood pressure in glaucoma pa- 
tients. Evaluation by linear regression revealed r 2 values 
of 0.3 (P = 0.03) for systolic, 0.39 (P = 0.007) for mean, 
and 0.47 (P = 0.003) for diastolic blood pressure. Also 
when expressed as AUC values, dose-response r lation- 
ships of endothelin-1 were correlated with systolic 
(P = 0.27, P = 0.05), mean (F = 0.5, P = 0.003), and 
diastolic blood pressure (r z = 0.54, P = 0.001) (Fig. 2). 
The mean phenylephrine dose-response r lationships 
of the two groups were similar (P = 0.3) and are shown 
in Fig. 3. Fitted mean log EDso (log ng/min, P = 0.37) 
and Emax (vasoconstriction expressed as percentage of 
baseline, P = 0.49) values for both groups were sim- 
ilar (controls:-0.35 +_ 0.1, 65% _+ 3.6; g laucoma: -  
0.47 +_ 0.1, 70% _+ 2.9). There was no correlation be- 
tween cq-adrenergic sensitivity (expressed as log EDso) 
or efficacy (expressed as Emax) and intra-arterial sys- 
tolic or diastolic blood pressure, either in controls or in 
glaucoma patients. 
Discussion 
The aim of this investigation was to test the main vaso- 
constrictor pathways involved in the regulation of vascu- 
lar tone in the human peripheral microcirculation. Al- 
though the regulation of the ocular circulation might be 
different from peripheral vascular beds [ 15], there is evi- 
dence for a relationship between peripheral forearm cir- 
culation and the ocular circulation in patients with va- 
sospastic syndromes [13]. The forearm vasculature was 
also chosen because this arterial bed only rarely devel- 
ops arteriosclerosis, and changes in vascular esponsive- 
ness therefore reflect functional rather than anatomic al- 
terations of the vessels. Moreover, this vascular bed ap- 
peared particularly suitable for these experiments since 
it has repeatedly been used to characterize functional 
abnormalities of vessels in patients with diseases affect- 
ing the vasculature [5, 16, 21, 27] and to study respon- 
siveness of the skin microcirculation [3, 35]. Finally, 
since only small doses are required to construct complete 
dose-response curves, systemic counter-regulatory re- 
flex activation is unlikely to occur or to confound the 
results. 
Whereas eq-adrenoceptor-mediated vasoconstriction 
was independent of blood pressure, endothelin-1 re- 
sponses were inversely correlated with systolic and dias- 
tolic values in glaucoma patients, indicating that patients 
with lower blood pressure were more sensitive to en- 
dothelin-1-induced vasoconstriction. This is of interest, 
since low blood pressure may promote glaucomatous 
damage although it is unclear by which mechanism. Ap- 
proximately 50% of the correlation between endothelin- 
1 responses and diastolic blood pressure in glaucoma 
patients was explained by this relationship. This is a 
rather emarkable finding, since vascular tone of forearm 
resistance arteries is also modulated by other effector 
pathways uch as spontaneous nitric oxide release [34]. 
To our knowledge, no data about he sensitivity of human 
vessels to endothelin-1 with respect to blood pressure are 
available. However, in accordance with our findings, in 
hypertensive rats, the sensitivity of vascular smooth 
muscle to endothelin-1 is reduced [7]. In the same study 
the response to norepinephrine did not differ between 
normo- and hypertensive animals, indicating that the re- 
duced sensitivity is endothelin-l-specific. Similar re- 
sults have also been reported in small subcutaneous ar- 
teries from patients with essential hypertension [33]. 
In almost all patients tudied, endothelin-1 evoked a 
biphasic response in cutaneous blood flow with vasodila- 
tion at lower and pronounced vasoconstriction at higher 
dose-rates. Biphasic effects of endothelin-1 have been 
reported earlier [20] and have been explained by the exis- 
tence of at least two receptors (ET A and ETB). Whereas 
the endothelium primarily expresses vasodilator ET B re- 
ceptors, vasoconstrictive ETA and ET B receptors are lo- 
cated on vascular smooth muscle cells [23]. Evidence 
has also been presented for the presence of both endothe- 
lin receptor subtypes in the microcirculation of porcine 
eyes and in isolated human choroidal and retinal vessels 
[22], indicating that endothelin- 1 can evoke dose-depen- 
dent vasodilator and vasoconstrictor effects also in the 
ocular microcirculation. 
In accordance with findings in patients with other va- 
sospastic disorders (Raynaud's disease [1]), (z~-adrener- 
gic responsiveness in glaucoma patients was similar to 
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controls, suggesting that differences in peripheral %- 
adrenoceptor sensitivity are absent and do not promote 
generalized vasospasms which are known to occur in 
certain glaucoma patients. 
The cause for the relationship between blood pressure 
and endothelin-1 responsiveness in the microcirculation 
of glaucoma patients is unknown, and the design of this 
study does not allow us to conclude whether these para- 
meters are only associated with each other or whether 
any of them is causally involved in the pathogenesis of
glaucoma. However, since endothelin-I responses are 
functionally linked to the activity of nitric oxide synthas- 
es, and since chronically administered NO may increase 
both the expression of ET A receptors and the affinity of 
the peptide to its receptor [30], it may be speculated that 
the blunted constrictor responses to endothelin-1 in hy- 
pertensive patients [33] and animals [7] are caused by 
decreases in NO production, which has been shown in 
some [21] but not all studies addressing this issue [27]. 
Collectively, these data may suggest hat glaucoma pa- 
tients tend to have higher NO production, which could 
subsequently cause increased vasoconstrictor responses 
to endothelin-1. Hence, future studies should focus on 
the evaluation of the effects of endothelin- 1, its antago- 
nists, and on the investigation of NO synthase activities in 
these patients. 
Obviously the results of this study were obtained in 
the peripheral microcirculation of the human forearm 
and not in the ocular circulation; therefore, they can only 
be extrapolated to the eye circulation. The local regula- 
tion of the ocular circulation is complex, has not yet been 
studied in all details [10, 36], and may differ in critical 
aspects from the peripheral microcirculation. Whereas 
choroidal vessels are amply innervated [11, 25] and flow 
is largely independent of autoregulation [ 19], retinal ves- 
sels are not innervated and local flow is controlled by 
efficient autoregulatory mechanisms imilar to those 
regulating cerebral blood flow [2, 29]. The vascular area 
of the optic nerve head which is critical in the pathogen- 
esis of glaucoma lso lacks autonomic innervation and is 
to some extent autoregulated [26, 28, 31]. However, 
blood supply of the optic nerve head mainly depends on 
the perfusion of the posterior ciliary arteries, which are 
regulated in a way similar to coronary and peripheral 
arteries [14]. In particular, all these ocular and extraocu- 
lar vessels have in common that they are rather sensitive 
to the vasoconstrictor effects of endothelin- 1 [4, 22, 23]. 
Thus, since systemic blood pressure is linked to periph- 
eral vascular sensitivity it appears possible that there is 
also a correlation with ocular vascular esponsiveness in 
these patients. This, however, remains to be shown in 
future studies including the ocular circulation. 
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